ORJ-001 achieved therapeutic exposure and was well tolerated in Phase 1 study, supporting company’s plans to initiate Phase 2 clinical trial in IPF patients ...

Company announces $30 million Series A financing and founding leadership team with expertise in pulmonary drug innovation and track record advancing novel therapies to patients ORJ-001, set to begin a ...

Governing AI Agents and Non‑Human Identities in Oracle, SAP, and Business‑Critical SaaS A Federated Control Plane for Human and Non‑Human Identities in SOX/ITGC‑Governed ERP Environments Executive ...

Prayagraj (UP), May 16 (PTI): The Allahabad High Court has ruled that under the Uttar Pradesh Revenue Code, the assistant collector (first class) is the competent authority to declare any transaction ...

First-in-human healthy volunteers trial showed SYX-5219 was safe and well toleratedSystemic immunomodulation of type 2 ...

Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...

Pieter Martens, MD, PhD (Hospital Oost-Limburg, Genk, Belgium), who made the “pro” case on behalf of IV iron, pointed out ...

Completed successful FDA End-of-Phase 2 meeting, reaching alignment on the study parameters of RESTORE, a registrational study of NVG-291 in chronic tetraplegia, with site activation underway and stud ...

The USS Gerald R. Ford, the world largest aircraft carrier, returned home to Virginia on Saturday after an 11-month ...

Here are the top 10 strongest Emitter Quirks from Class 1-A in My Hero Academia, ranked by power and versatility.

“Gabin” is far from the first film - nonfiction or otherwise - to make a longterm investment in a child protagonist, training ...

Hyundai needs to be applauded for giving people what they want – a straightforward compact SUV, writes Jim McGill ...